Literature DB >> 1825184

Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis.

T Niwa1, H Yoshizumi, Y Emoto, T Miyazaki, N Hashimoto, N Takeda, A Tatematsu, K Maeda.   

Abstract

Quinolinic acid was first identified in uremic serum by use of gas chromatography/mass spectrometry. Quantification by selected ion monitoring revealed that the serum concentration of quinolinic acid was markedly increased in chronic hemodialysis patients, and that the acid could be removed by conventional hemodialysis. The serum concentration of quinolinic acid was weakly but significantly correlated with the serum uric acid concentration. Accumulation of quinolinic acid in uremic blood may be involved in the pathogenesis of anemia, suppressed immune system, and uremic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825184

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.

Authors:  D Pawlak; K Pawlak; J Malyszko; M Mysliwiec; W Buczko
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Jovia L Nierenberg; Jiang He; Changwei Li; Xiaoying Gu; Mengyao Shi; Alexander C Razavi; Xuenan Mi; Shengxu Li; Lydia A Bazzano; Amanda H Anderson; Hua He; Wei Chen; Jason M Kinchen; Casey M Rebholz; Josef Coresh; Andrew S Levey; Lesley A Inker; Michael Shlipak; Tanika N Kelly
Journal:  Metabolomics       Date:  2019-11-13       Impact factor: 4.290

3.  4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism.

Authors:  A Laurence; S M Edbury; A M Marinaki; R T Smolenski; D J A Goldsmith; H A Simmonds; E A Carrey
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

Review 4.  Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?

Authors:  Adrian Mor; Bartlomiej Kalaska; Dariusz Pawlak
Journal:  Int J Tryptophan Res       Date:  2020-09-21

5.  Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro.

Authors:  Erman Popowski; Benjamin Kohl; Tobias Schneider; Joachim Jankowski; Gundula Schulze-Tanzil
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

Review 6.  Thrombolome and Its Emerging Role in Chronic Kidney Diseases.

Authors:  Justyna Fryc; Beata Naumnik
Journal:  Toxins (Basel)       Date:  2021-03-18       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.